American Healthcare REIT AHR Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain at other companies
Other financials
Where this comes from
Reported directly by American Healthcare REIT in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain.
The official record: American Healthcare REIT’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →
Ask your AI about American Healthcare REIT's business combination step acquisition equity interest in acquiree remeasurement gain.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is American Healthcare REIT's business combination step acquisition equity interest in acquiree remeasurement gain?
- American Healthcare REIT (AHR) reported business combination step acquisition equity interest in acquiree remeasurement gain of $14.58M in Q3 2025.
- What is the long-term trend for American Healthcare REIT's business combination step acquisition equity interest in acquiree remeasurement gain?
- Over 2 years (2022 to 2024), American Healthcare REIT's business combination step acquisition equity interest in acquiree remeasurement gain has grown at a -100.0% compound annual growth rate (CAGR), from $19.57M to $0.
- What does business combination step acquisition equity interest in acquiree remeasurement gain mean?
- A non-cash accounting gain from revaluing existing ownership stakes when acquiring a controlling interest.
- How do you interpret business combination step acquisition equity interest in acquiree remeasurement gain?
- A gain indicates that the value of the previously held interest has increased, reflecting successful investment performance prior to full acquisition.
- How does business combination step acquisition equity interest in acquiree remeasurement gain compare across companies?
- Common in companies pursuing aggressive M&A strategies; peers often report this as a one-time non-operating item.